New York Passes Radical New Marijuana Law

The last dominoes are on their way down for federal legalization. As of last month, thousands of New Yorkers are now eligible to have low-level marijuana convictions permanently removed from their records. The last dominoes are on their way down for federal legalization. You are receiving this email because you subscribed to Wealth Daily. [Click here]( to manage your e-mail preferences. [Wealth Daily logo] New York Passes Radical New Marijuana Law [Alex Koyfman Photo] By [Alex Koyfman]( Written Sep. 26, 2019 Dear Reader, As of last month, thousands of New Yorkers are now eligible to have low-level marijuana convictions permanently removed from their records. It's the sort of legislation that legal cannabis proponents have been campaigning for in states across the country. Colorado, California, Maryland, New Hampshire, and Oregon have also made it possible for people convicted of some crimes of marijuana possession, cultivation, or manufacture to get their records sealed or expunged, which generally means removing convictions from public databases. New York's approach, however, is among the most progressive to date. Individuals with convictions for possession of marijuana as a class B misdemeanor will have their convictions automatically stricken from their records — without having to submit applications to do so. More than 13,000 individuals from the five boroughs automatically had their New York criminal records scrubbed as of the day the law went into effect. Across the state, the law will affect another 11,000 residents. Leaked: The Next Apple Is Secretly Preparing Its IPO One incredible company is generating billions of dollars on what Business Insider is calling “the best smartphone you’ve never heard of.” Tech industry insiders are already salivating at its product lineup, which some believe could make it a trillion-dollar tech giant on par with Apple, Google, and Amazon. Revenues last year were up by 32%, versus Apple’s 6% rise. [Click here to learn all the details about the next Apple!]( The Bigger Picture So what does this mean for the state of cannabis in the U.S. in the grand scheme of things? It means the last dominoes are on their way down for federal legalization. As of today, two of the three most populous states now have these conviction-reversal statutes in place, indicating that the legal climate for cannabis has become favorable in the mainstream. In addition, Maryland — one of the two states bordering the nation's capital, which itself decriminalized marijuana five years ago — has fallen in line with this philosophy of leniency toward past offenders. Though the cannabis sector as a whole has been hurting as of late, with the North American Marijuana Index dropping by nearly half, the ultimate catalyst cannabis investors have been awaiting is still in the offing, and drawing nearer. For the savviest of investors, this marks an important milestone in the story of legal cannabis. Once the mania subsides and the biggest cash cows of the initial boom are slaughtered (look no further than Tilray and Canopy Growth, which were 82% and 54% off their peaks, respectively, when the New York legislation went into effect), the real winners of the long-term bull market will start to emerge. The Multi-Armed $0.30 Pot Stock to Buy Now The cannabis industry is currently valued at $9.2 billion and is expected to rise over $47 billion over the next few years. Cannabis is 100% legal in Canada. And now legalization is spreading like wildfire across the United States. When it comes to investing in pot stocks, picking the right one is crucial. Luckily, investment director Alex Koyfman has discovered the perfect pot stock... for under $0.30 a share! This company is a multi-armed beast, participating in a multitude of markets, from infrastructure to food to technology. Here are just a few things this company’s involved in: - It has a 1,000-acre deal in Nevada where farmers can make more than $1,000,000 per acre. - It has a large interest in 40,000 square feet worth of indoor growing facilities in California. - It’s developing its own line of cannabis-infused soft drinks, a $200 billion industry that even Coca-Cola is about to get in on. 
This company could see revenue increase over 3,000%! This is your chance to pick this up at $0.30. Don’t miss the boat... [Click here now to get all the details.]( After the Blood in the Streets Has Dried That makes today's choice all the more important. With the entire cannabis sector scratching all-time lows, while the legislative landscape continues to move toward federal decriminalization, the biggest opportunities will be captured (or lost) in the coming months. So what would I do in your shoes right now? Well, I would start with a company that's got a solid business model. Not a mere producer. Not a mere retailer. Not a mere property owner. Not a mere product developer, but a company that does it all: grows the crop, develops the product, and markets the product, all on its properties, which it also leases to other brands. I would make sure the company is young and small, with most of its growth still in the future. And, perhaps most important of all, I would find a company that's been irrationally hammered by the recent sector-wide downturn. Once all those boxes were checked, I would bide my time, wait for an opening, buy in, and get ready to wait out the next several months while the market gets back to reflecting reality. A Future Star Rises How many such companies fit all those criteria? Not many... [But there is one in particular that fits this model to a T.]( I've been looking at this stock for months now, and I've compiled [a detailed report on what sets it apart from the rest](. Right now might be the best time ever to initiate a position. But don't take my word for it. Check the data and see for yourself. [Here's my report to start you off.]( Fortune favors the bold, [alex koyfman Signature] Alex Koyfman [[follow basic]@AlexKoyfman on Twitter]( Coming to us from an already impressive career as an independent trader and private investor, Alex's specialty is in the often misunderstood but highly profitable development-stage microcap sector. Focusing on young, aggressive, innovative biotech and technology firms from the U.S. and Canada, Alex has built a track record most Wall Street hedge funders would envy. Alex contributes his thoughts and insights regularly to [Wealth Daily](. To learn more about Alex, [click here](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Recession or Not: Part II]( [Datadog Soared 49% on its IPO]( [Recession or Not?]( [Avoid Tax-Advantaged Investments in Your Retirement Account]( [Stating the Obvious: Beyond Meat (NASDAQ: BYND) Is Priced Beyond Perfection]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2019, [Angel Publishing LLC](. All rights reserved. 111 Market Place #720 Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.